Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1973 May 5;2(5861):257–258. doi: 10.1136/bmj.2.5861.257

A marker for medullary carcinoma of thyroid.

PMCID: PMC1589168  PMID: 4350109

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baylin S. B., Beaven M. A., Buja L. M., Keiser H. R. Histaminase activity: a biochemical marker for medullary carcinoma of the thyroid. Am J Med. 1972 Dec;53(6):723–733. doi: 10.1016/0002-9343(72)90189-1. [DOI] [PubMed] [Google Scholar]
  2. Baylin S. B., Beaven M. A., Engelman K., Sjoerdsma A. Elevated histaminase activity in medullary carcinoma of the thyroid gland. N Engl J Med. 1970 Dec 3;283(23):1239–1244. doi: 10.1056/NEJM197012032832301. [DOI] [PubMed] [Google Scholar]
  3. Baylin S. B., Beaven M. A., Keiser H. R., Tashjian A. H., Jr, Melvin K. E. Serum histaminase and calcitonin levels in medullary carcinoma of the thyroid. Lancet. 1972 Feb 26;1(7748):455–458. doi: 10.1016/s0140-6736(72)90120-1. [DOI] [PubMed] [Google Scholar]
  4. Melvin K. E., Miller H. H., Tashjian A. H., Jr Early diagnosis of medullary carcinoma of the thyroid gland by means of calcitonin assay. N Engl J Med. 1971 Nov;285(20):1115–1120. doi: 10.1056/NEJM197111112852004. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES